187 related articles for article (PubMed ID: 17910620)
21. Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content.
Modarai M; Gertsch J; Suter A; Heinrich M; Kortenkamp A
J Pharm Pharmacol; 2007 Apr; 59(4):567-73. PubMed ID: 17430641
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of metabolism-mediated herb-drug interactions.
Na DH; Ji HY; Park EJ; Kim MS; Liu KH; Lee HS
Arch Pharm Res; 2011 Nov; 34(11):1829-42. PubMed ID: 22139684
[TBL] [Abstract][Full Text] [Related]
23. Tryptamine: a possible endogenous substrate for CYP2D6.
Martínez C; Agúndez JA; Gervasini G; Martín R; Benítez J
Pharmacogenetics; 1997 Apr; 7(2):85-93. PubMed ID: 9170145
[TBL] [Abstract][Full Text] [Related]
24. Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity.
Zou L; Harkey MR; Henderson GL
Life Sci; 2002 Aug; 71(13):1579-89. PubMed ID: 12127912
[TBL] [Abstract][Full Text] [Related]
25. Exploring the possible metabolism mediated interaction of Glycyrrhiza glabra extract with CYP3A4 and CYP2D6.
Pandit S; Ponnusankar S; Bandyopadhyay A; Ota S; Mukherjee PK
Phytother Res; 2011 Oct; 25(10):1429-34. PubMed ID: 21351298
[TBL] [Abstract][Full Text] [Related]
26. Herbal supplements and therapeutic drug monitoring: focus on digoxin immunoassays and interactions with St. John's wort.
Dasgupta A
Ther Drug Monit; 2008 Apr; 30(2):212-7. PubMed ID: 18367983
[TBL] [Abstract][Full Text] [Related]
27. Mechanism-based inactivation of CYP2D6 by methylenedioxymethamphetamine.
Heydari A; Yeo KR; Lennard MS; Ellis SW; Tucker GT; Rostami-Hodjegan A
Drug Metab Dispos; 2004 Nov; 32(11):1213-7. PubMed ID: 15328252
[TBL] [Abstract][Full Text] [Related]
28. Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers.
Markowitz JS; DeVane CL; Boulton DW; Carson SW; Nahas Z; Risch SC
Life Sci; 2000 Jan; 66(9):PL133-9. PubMed ID: 10698361
[TBL] [Abstract][Full Text] [Related]
29. An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents.
Etheridge AS; Black SR; Patel PR; So J; Mathews JM
Planta Med; 2007 Jul; 73(8):731-41. PubMed ID: 17611934
[TBL] [Abstract][Full Text] [Related]
30. The molecular basis of CYP2D6-mediated N-dealkylation: balance between metabolic clearance routes and enzyme inhibition.
Bonn B; Masimirembwa CM; Aristei Y; Zamora I
Drug Metab Dispos; 2008 Nov; 36(11):2199-210. PubMed ID: 18725510
[TBL] [Abstract][Full Text] [Related]
31. Substrate specific metabolism by polymorphic cytochrome P450 2D6 alleles.
Bogni A; Monshouwer M; Moscone A; Hidestrand M; Ingelman-Sundberg M; Hartung T; Coecke S
Toxicol In Vitro; 2005 Aug; 19(5):621-9. PubMed ID: 15893449
[TBL] [Abstract][Full Text] [Related]
32. Phenotyping studies to assess the effects of phytopharmaceuticals on in vivo activity of main human cytochrome p450 enzymes.
Zadoyan G; Fuhr U
Planta Med; 2012 Sep; 78(13):1428-57. PubMed ID: 22588833
[TBL] [Abstract][Full Text] [Related]
33. Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea.
Gurley BJ; Swain A; Hubbard MA; Williams DK; Barone G; Hartsfield F; Tong Y; Carrier DJ; Cheboyina S; Battu SK
Mol Nutr Food Res; 2008 Jul; 52(7):755-63. PubMed ID: 18214849
[TBL] [Abstract][Full Text] [Related]
34. An approach to the in vitro evaluation of potential for cytochrome P450 enzyme inhibition from herbals and other natural remedies.
Strandell J; Neil A; Carlin G
Phytomedicine; 2004 Feb; 11(2-3):98-104. PubMed ID: 15070158
[TBL] [Abstract][Full Text] [Related]
35. Metabolism of dextrorphan by CYP2D6 in different recombinantly expressed systems and its implications for the in vitro assessment of dextromethorphan metabolism.
Van LM; Sarda S; Hargreaves JA; Rostami-Hodjegan A
J Pharm Sci; 2009 Feb; 98(2):763-71. PubMed ID: 18543297
[TBL] [Abstract][Full Text] [Related]
36. Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYP2D6.
Yu AM; Idle JR; Byrd LG; Krausz KW; Küpfer A; Gonzalez FJ
Pharmacogenetics; 2003 Mar; 13(3):173-81. PubMed ID: 12618595
[TBL] [Abstract][Full Text] [Related]
37. Multiple night-time doses of valerian (Valeriana officinalis) had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteers.
Donovan JL; DeVane CL; Chavin KD; Wang JS; Gibson BB; Gefroh HA; Markowitz JS
Drug Metab Dispos; 2004 Dec; 32(12):1333-6. PubMed ID: 15328251
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of St. John's wort (hypericum) during pregnancy and lactation.
Dugoua JJ; Mills E; Perri D; Koren G
Can J Clin Pharmacol; 2006; 13(3):e268-76. PubMed ID: 17085775
[TBL] [Abstract][Full Text] [Related]
39. Phe120 contributes to the regiospecificity of cytochrome P450 2D6: mutation leads to the formation of a novel dextromethorphan metabolite.
Flanagan JU; Maréchal JD; Ward R; Kemp CA; McLaughlin LA; Sutcliffe MJ; Roberts GC; Paine MJ; Wolf CR
Biochem J; 2004 Jun; 380(Pt 2):353-60. PubMed ID: 14992686
[TBL] [Abstract][Full Text] [Related]
40. Minimizing polymorphic metabolism in drug discovery: evaluation of the utility of in vitro methods for predicting pharmacokinetic consequences associated with CYP2D6 metabolism.
Gibbs JP; Hyland R; Youdim K
Drug Metab Dispos; 2006 Sep; 34(9):1516-22. PubMed ID: 16763018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
